Reactive oxygen species induce formation of
15-F(2t)-isoprostane (15-F(2t)-IsoP), a specific marker of in vivo lipid peroxidation, which is increased after
myocardial ischemia and during the subsequent reperfusion.
15-F(2t)-IsoP possesses potent bioactivity under pathophysiological conditions. However, it remains unknown whether
15-F(2t)-IsoP, by itself, can influence
myocardial ischemia-
reperfusion injury (IRI). Adult rat hearts were perfused by the Langendorff technique with Krebs-Henseleit (KH)
solution at a constant flow rate of 10 ml/min.
15-F(2t)-IsoP (100 nM),
SQ-29548 (1 microM, SQ), a
thromboxane receptor antagonist that can abolish the
vasoconstrictor effect of
15-F(2t)-IsoP,
15-F(2t)-IsoP + SQ in KH, or KH alone (vehicle control) was applied for 10 min before induction of 40 min of global
ischemia followed by 60 min of reperfusion. During
ischemia, saline (control),
15-F(2t)-IsoP,
15-F(2t)-IsoP + SQ, or SQ in saline was perfused through the aorta at 60 microl/min.
15-F(2t)-IsoP,
15-F(2t)-IsoP + SQ, or SQ in KH was infused during the first 15 min of reperfusion. Coronary effluent
endothelin-1 concentrations were significantly higher in the group treated with
15-F(2t)-IsoP than in the control group during
ischemia and also in the later phase of reperfusion (P < 0.05). Infusion of
15-F(2t)-IsoP increased release of cardiac-specific
creatine kinase, reduced cardiac contractility during reperfusion, and increased
myocardial infarct size relative to the control group. SQ abolished the deleterious effects of
15-F(2t)-IsoP.
15-F(2t)-IsoP exacerbates myocardial IRI and may, therefore, act as a mediator of IRI. 15-F(2t)-IsoP-induced
endothelin-1 production during cardiac reperfusion may represent a mechanism underlying the deleterious actions of
15-F(2t)-IsoP.